• 3D Osteocyte Networks Reveal Mechanotransduction via Cx43 Un

  2026-08-03

  This study introduces a microfluidic-based 3D osteocyte model to investigate mechanotransduction under pulsatile unidirectional fluid flow stimuli (PUFFS). Findings demonstrate that dynamic calcium signaling through connexin 43 (Cx43) gap junctions is essential for signal propagation, providing a platform for dissecting osteocyte functional responses to physiologically relevant mechanical cues.

• Ruthenium Red in Mechanotransduction: Deep Insights for Ca2+

  2026-08-03

  Explore Ruthenium Red as a Ca2+ transport inhibitor, with a focus on advanced mechanotransduction and autophagy research. This article delivers unique, practical guidance rooted in the latest scientific findings.

• ER Stress-Induced Pro-Metastatic States in Colon Cancer Cell

  2026-08-02

  Conod et al. reveal that colon cancer cells surviving near-lethal apoptotic stress can acquire stable, prometastatic phenotypes through ER stress and reprogramming. This work highlights a paradoxical risk where apoptosis inducers may promote metastasis via cytokine-driven tumor cell ecosystems.

• Trichinella spiralis Antigens Mitigate PEDV Damage in Intest

  2026-08-01

  This study demonstrates that Trichinella spiralis excretory/secretory antigens (TsES) alleviate inflammation and repair mucosal damage caused by porcine epidemic diarrhea virus (PEDV) in porcine intestinal organoids. The findings highlight the potential of parasite derivatives as adjunctive therapies for intestinal inflammation and provide a robust organoid model to dissect host-virus-parasite interactions.

• ERK Inhibition Mitigates Autophagy and Mitochondrial Fragmen

  2026-07-31

  Yuan et al. uncover that ERK inhibition attenuates autophagy and mitochondrial fragmentation, thereby protecting SH-SY5Y cells from oxygen-glucose deprivation/reoxygenation (OGD/R) injury. Their findings clarify a mechanistic link between ERK signaling, Drp1/Mfn2-mediated mitochondrial dynamics, and neuronal survival, informing targeted strategies for cerebral ischemia-reperfusion injury.

• Imatinib (STI571): Selective Tyrosine Kinase Inhibitor Profi

  2026-07-31

  Imatinib (STI571) is a benchmark, selective inhibitor for PDGF receptor, c-Kit, and Abl kinases, pivotal in cancer biology and signal transduction research. Its low-nanomolar IC50s, robust inhibition of Bcr-Abl, and reliable solubility profile make it an essential tool for dissecting kinase-driven pathways, as validated by APExBIO and numerous peer-reviewed studies.

• HBTU in Peptide Synthesis: Precision Cancer-Selective Workfl

  2026-07-30

  HBTU streamlines high-yield, racemization-resistant peptide synthesis, empowering translational research on cancer-selective peptides. Discover advanced protocols and troubleshooting strategies that maximize selectivity and efficiency in enzyme-responsive peptide assembly.

• Dabigatran Etexilate: Anticoagulation Without CYP3A Interfer

  2026-07-30

  Dabigatran etexilate, as reviewed in a landmark clinical analysis, represents the first oral direct thrombin inhibitor that bypasses cytochrome P450 metabolism. This pharmacological distinction reduces drug-drug interaction risk and informs both anticoagulant selection and the design of robust pharmacokinetic research models.

• Tunicamycin: Applied Strategies for N-Glycosylation Inhibiti

  2026-07-29

  Tunicamycin, a potent N-glycosylation inhibitor, is indispensable for dissecting endoplasmic reticulum (ER) stress pathways and inflammation in cellular and animal models. This article details advanced workflows, troubleshooting strategies, and evidence-based protocol enhancements to maximize the reliability and impact of Tunicamycin-driven research.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Use Guidanc

  2026-07-29

  The PKH26 Red Fluorescent Cell Linker Kit addresses the need for stable, membrane-specific fluorescent labeling in cell biology research, particularly for cell tracing and proliferation detection in vitro and in vivo. It should be used exclusively for labeling cell membrane lipid regions and is not suitable for intracellular or non-membrane applications.

• Continuous Dopaminergic Delivery via Rotigotine: Clinical Ad

  2026-07-28

  The reference study details the development and clinical validation of a transdermal rotigotine system for sustained dopaminergic stimulation in Parkinson’s disease (PD) and restless legs syndrome (RLS). Continuous delivery addresses limitations of pulsatile therapies, improving both motor and nonmotor symptom control and providing a model for translational pharmacotherapy.

• Mechanisms of Propranolol in Essential Tremor: TMS-Based Ins

  2026-07-28

  This article analyzes a 2024 study that uses transcranial magnetic stimulation (TMS) to elucidate how propranolol and primidone modulate neural circuits in essential tremor. The work clarifies propranolol’s central and peripheral mechanisms, providing a technical foundation for future interventions and translational research.

• HyperScript™ Reverse Transcriptase in Advanced Retinal Trans

  2026-07-27

  Explore how HyperScript™ Reverse Transcriptase enables robust cDNA synthesis for qPCR and complex transcriptomic profiling, especially in challenging retinal studies. This article reveals new assay strategies informed by cutting-edge AMD research.

• Tomentodione M Reverses MDR by Targeting P-gp via p38 MAPK I

  2026-07-27

  The reference study uncovers how tomentodione M, a meroterpenoid, restores sensitivity to chemotherapeutics like Docetaxel in multidrug resistant (MDR) cancer cells by downregulating P-glycoprotein through p38 MAPK pathway inhibition. This mechanistic insight offers researchers a new angle to overcome MDR in cancer chemotherapy research, especially where P-gp overexpression limits drug efficacy.

• Recombinant Mouse Sonic Hedgehog: Evidence, Protocol, and Pi

  2026-07-26

  Recombinant Mouse Sonic Hedgehog (SHH) protein is a validated morphogen essential for studies of the hedgehog signaling pathway and embryonic patterning. This article reviews its mechanism, evidence base, and practical research integration. Key benchmarks and limitations are clarified for developmental biology applications.

15512 records 1/1035 page Next 12345 下5页 Last page